Repurposed drugs (R&D)

Drug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse of existing licensed drugs for new medical indications. It involves establishing new therapeutic uses for already known drugs. Repurposing existing drugs is attractive as the development process is often less risky and shorter in time. Therefore repurposing existing medicines offers a cost-efficient way to increase patients’ treatment options and ensures accessible, sustainable and affordable drugs.

Arega invests in research to identify new therapeutic uses for approved drugs and cooperates with the University of Maastricht for several repurposing projects.

Are you a healthcare professional and interested in learning more about our research projects ?